| Pharmaceutical Information |
| Drug Name |
Benzylamphetamine |
| Drug ID |
BADD_D00249 |
| Description |
A sympathomimetic agent with properties similar to dextroamphetamine. It is used in the treatment of obesity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1222) |
| Indications and Usage |
For the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction |
| Marketing Status |
approved; illicit |
| ATC Code |
Not Available |
| DrugBank ID |
DB00865
|
| KEGG ID |
Not Available
|
| MeSH ID |
C015024
|
| PubChem ID |
10149140
|
| TTD Drug ID |
D0T5UL
|
| NDC Product Code |
Not Available |
| UNII |
1OV1CK7BED
|
| Synonyms |
benzylamphetamine | N-benzylamphetamine | desmethylbenzphetamine | benzylamphetamine, (-)-isomer | benzylamphetamine, (+)-isomer |
|
| Chemical Information |
| Molecular Formula |
C16H19N |
| CAS Registry Number |
156-08-1 |
| SMILES |
CC(CC1=CC=CC=C1)NCC2=CC=CC=C2 |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
